Characteristic analyses of a neural differentiation model from iPSC-derived neuron according to morphology, physiology, and global gene expression pattern.
- Authors
- Kang, Sai; Chen, Xiaoxia; Gong, Siyi; Yu, Panpan; Yau, SukYu; Su, Zhenghui; Zhou, Libing; Yu, Jiandong; Pan, Guangjin; Shi, Lingling
- Year
- 2017
- Journal
- Scientific reports
- PMID
- 28947763
- DOI
- 10.1038/s41598-017-12452-x
- PMCID
- PMC5612987
Induced pluripotent stem cells (iPSCs) can differentiate into neural progenitor cells (NPC) under proper conditions. NPC can be used as a model and is a useful tool for disease mechanism exploration and drug screening. However, the characteristics of the cells in various stages from NPC to functional neurons have not been fully described. This study investigated the characteristics of iPSC-derived NPCs during differentiation. Morphological characteristics of the NPCs, including soma area, neurite length, and the number of neurite branches, were examined on selected differentiation days. Physiological functions were assessed by recordings of sodium current, spontaneous excitatory postsynaptic current (sEPSC), and spontaneous inhibitory postsynaptic current (sIPSC). Furthermore, gene expression patterns were assessed with RNA-seq. We found that NPCs derived from iPSCs can be differentiated into glutamatergic and gabaergic neurons. Cell growth peaked during differentiation day 7-12, as the soma area decreased after day 12, growth cone and the number of branches peaked at day 9 and decreased afterwards; whereas a functional synapse formed after day 23. RNA-seq analysis found that a differential expression pattern emerged by day 7. Overall, the study provides a framework for the differentiation process of hiPSC-derived NPCs.
In vitro neural development model. Neural progenitor cells (NPCs) were differentiated from hiPSCs, which were then further induced to differentiate into neurons (A–H). The majority of cells differentiated from hiPSCs stained positive for NESTIN, indicating the cells were NPCs (E). NPCs derived from hiPSC maintained differentiation potential. HiPSC derived NPCs can diffentiated into both neural and glial lineage as stained by neuron marker TUJ-1, astrocyte marker GFAP (I–L).
The area of soma increased during development. The soma area of the cultured neurons increased significantly when measured on D9, D12 and D15, compared with D3 (n = 60, ***P < 0.05).
Both the length and the number of branches of neuritis increased during NPC maturation. (A) Cells expressing RFP were used for morphological study. The length of neuritis and the number of branches were measured and counted. (B–D) The number of primary and secondary branches of neurites reached a peak on D9. The number of primary branches showed a decreasing trend after D9. (E–G) The length of neurites reached a peak on D12 (n = 10 for D9, n = 20 for D3, D6, D12 and D15 measurement, ***P < 0.001, **P < 0.01, *P < 0.05).
Development pattern of the growth cone. (A) The growth cones are categorized into three subtypes: blunt-ended (collapsed with no visible filopodia or lamellipodia), filopodial (growth cones with numerous filopodia and a small or absent lamellipodial veil), or lamellipodial (well spread growth cones with elaborate lamellipodia). (B) Area of growth cone reached a peak on D9. (C) The percentage of the lamellipodial type growth cone increased before D9 and then decreased (n = 60, ***P < 0.001, *P < 0.05).
Sodium channels were expressed in early days of differentiation, but became functional only in later days. (A) RFP expressing cell visualized under microscope. (B) Sodium current traces recorded from cultured cells on different days during differentiation. (C) The depolarization that was required to elicit sodium current decreased. (D) The amplitude of sodium current increased. (E) The resting membrane potential of cultured cells decreased. (F) The capacitance of the cultured cells increased. (G) The membrane resistance of the cells decreased.
Frequency of sEPSCs and sIPSC progressively increased. (A) Example sEPSC traces recorded from a cultured cell. (B) The amplitude of the EPSCs increased. (C) The frequency of EPSC increased. (D) The charges transferred between cultured cells increased. (E) Example sIPSC traces recorded from a cultured cell. (F) The amplitude of sIPSC increased. (G) The frequency of sIPSC increased. (H) The charges transferred between cultured cells increased.
The enriched gene modules were divided into three groups by trend in expression. Squares with colors indicate a P value of <0.01. Four modules (red, No. 11, 12, 13, 15) belong to the increasing gene expression module, 2 modules (yellow, No. 2, 3) belong to the decreasing cluster, and the expression level of 2 modules (purple and green, No 1, 14) correlate with disorders.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Alcohol reverses the effects of KCNJ6 (GIRK2) noncoding variants on excitability of human glutamatergic neurons. | 2023 | 36207584 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Cell Density Impacts Population Activity in Human iPSC-Derived Neural Networks. | Uzun YS et al. | — | 2026 | → |
| Unraveling the Morphological and Functional Maturation Mechanisms Underlying Human Neural Development Using iPSCs-Derived Neuronal Model. | Tian Y et al. | — | 2026 | → |
| Human-Induced Pluripotent Stem Cells (iPSCs) for Disease Modeling and Insulin Target Cell Regeneration in the Treatment of Insulin Resistance: A Review. | Thiab S et al. | — | 2025 | → |
| Implementing a trilineage differentiation in the ReproTracker assay for improved teratogenicity assessment. | Horcas-Nieto JM et al. | — | 2025 | → |
| Integrative computational and experimental evaluation of retinoic acid role in promoting Wharton's jelly-derived mesenchymal stem cells differentiation into neuronal cells. | Ranjan S et al. | — | 2025 | → |
| Multifactorial approach is needed to unravel the maturation phases of human neurons derived from induced pluripotent stem cells. | Ben Mahmoud M et al. | — | 2025 | → |
| Pulsed electromagnetic stimulation promotes neuronal maturation by up-regulating cholesterol biosynthesis. | Chen P et al. | — | 2025 | → |
| Selenium promotes neural development through the regulation of GPX4 and SEPP1 in an iPSC-derived neuronal model. | Dai Z et al. | — | 2025 | → |
| Vascular models of Alzheimer's disease: An overview of recent in vitro models of the blood-brain barrier. | Takeuchi LE et al. | — | 2025 | → |
| A comprehensive protocol for efficient differentiation of human NPCs into electrically competent neurons. | Romito E et al. | — | 2024 | → |
| Activity-Dependent Transcriptional Program in NGN2+ Neurons Enriched for Genetic Risk for Brain-Related Disorders. | Ma Y et al. | — | 2024 | → |
| Altered Expression of PDE4 Genes in Schizophrenia: Insights from a Brain and Blood Sample Meta-Analysis and iPSC-Derived Neurons. | Burrack N et al. | — | 2024 | → |
| Effects of Physical Cues on Stem Cell-Derived Extracellular Vesicles toward Neuropathy Applications. | Berry D et al. | — | 2024 | → |
| Integrative analysis of long isoform sequencing and functional data identifies distinct cortical layer neuronal subtypes derived from human iPSCs. | Zehra B et al. | — | 2024 | → |
| Neuropathogenesis-on-chips for neurodegenerative diseases. | Amartumur S et al. | — | 2024 | → |
| Stem cell-based approaches for developmental neurotoxicity testing. | Ku J et al. | — | 2024 | → |
| Alcohol reverses the effects of KCNJ6 (GIRK2) noncoding variants on excitability of human glutamatergic neurons. | Popova D et al. | — | 2023 | → |
| Effects of Rhazya Stricta plant organic extracts on human induced pluripotent stem cells derived neural stem cells. | Alawad AO et al. | — | 2023 | → |
| Platform-agnostic CellNet enables cross-study analysis of cell fate engineering protocols. | Lo EKW et al. | — | 2023 | → |
| Priming mesenchymal stromal cells with neurotrophic factors boosts the neuro-regenerative potential of their secretome. | Teli P et al. | — | 2023 | → |
| Semi-Automated Quantitative Evaluation of Neuron Developmental Morphology In Vitro Using the Change-Point Test. | Liao AS et al. | — | 2023 | → |
| Simulating traumatic brain injury <i>in vitro</i>: developing high throughput models to test biomaterial based therapies. | Basit RH et al. | — | 2023 | → |
| 16p13.11 deletion variants associated with neuropsychiatric disorders cause morphological and synaptic changes in induced pluripotent stem cell-derived neurons. | Buttermore ED et al. | — | 2022 | → |
| Combinatorial Approach of Binary Colloidal Crystals and CRISPR Activation to Improve Induced Pluripotent Stem Cell Differentiation into Neurons. | Urrutia-Cabrera D et al. | — | 2022 | → |
| Electrophysiological- and Neuropharmacological-Based Benchmarking of Human Induced Pluripotent Stem Cell-Derived and Primary Rodent Neurons. | Jezierski A et al. | — | 2022 | → |
| Increased connectivity of hiPSC-derived neural networks in multiphase granular hydrogel scaffolds. | Hsu CC et al. | — | 2022 | → |
| Increased excitability of human iPSC-derived neurons in HTR2A variant-related sleep bruxism. | Sarkar AK et al. | — | 2022 | → |
| Insights into SACS pathological attributes in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)☆. | Aly KA et al. | — | 2022 | → |
| Neuroprotective effect of phospholipase A<sub>2</sub> from Malaysian <i>Naja sumatrana</i> venom against H<sub>2</sub>O<sub>2</sub>-induced cell damage and apoptosis. | Abdullah NAH et al. | — | 2022 | → |
| Retroviral infection of human neurospheres and use of stem Cell EVs to repair cellular damage. | Branscome H et al. | — | 2022 | → |
| Tissue-Engineered Models of the Human Brain: State-of-the-Art Analysis and Challenges. | Tarricone G et al. | — | 2022 | → |
| Deconstructing Alzheimer's Disease: How to Bridge the Gap between Experimental Models and the Human Pathology? | Vignon A et al. | — | 2021 | → |
| Electrochemical Impedance Spectroscopy as a Tool for Monitoring Cell Differentiation from Floor Plate Progenitors to Midbrain Neurons in Real Time. | Elghajiji A et al. | — | 2021 | → |
| Engineered Human Induced Pluripotent Cells Enable Genetic Code Expansion in Brain Organoids. | van Husen LS et al. | — | 2021 | → |
| Hypothalamus and neuroendocrine diseases: The use of human-induced pluripotent stem cells for disease modeling. | de Souza Santos R et al. | — | 2021 | → |
| Isolation and characterization of neural stem cells from fetal canine spinal cord. | Santos SIP et al. | — | 2021 | → |
| Retroviral Infection of Human Neurospheres and Use of Stem Cell EVs to Repair Cellular Damage | Branscome H et al. | — | 2021 | — |
| Challenges in Physiological Phenotyping of hiPSC-Derived Neurons: From 2D Cultures to 3D Brain Organoids. | Mateos-Aparicio P et al. | — | 2020 | → |
| Chromatin Interaction Changes during the iPSC-NPC Model to Facilitate the Study of Biologically Significant Genes Involved in Differentiation. | Choi WY et al. | — | 2020 | → |
| Effect of Laminin Derived Peptides IKVAV and LRE Tethered to Hyaluronic Acid on hiPSC Derived Neural Stem Cell Morphology, Attachment and Neurite Extension. | Perera TH et al. | — | 2020 | → |
| Insulin-like growth factor 1 partially rescues early developmental defects caused by SHANK2 knockdown in human neurons. | Chen ST et al. | — | 2020 | → |
| Methods of Generation of Induced Pluripotent Stem Cells and Their Application for the Therapy of Central Nervous System Diseases. | Cherkashova EA et al. | — | 2020 | → |
| Misconnecting the dots: altered mitochondrial protein-protein interactions and their role in neurodegenerative disorders. | Zilocchi M et al. | — | 2020 | → |
| Modelling multiple sclerosis using induced pluripotent stem cells. | Martínez-Larrosa J et al. | — | 2020 | → |
| NEUROD1 Intrinsically Initiates Differentiation of Induced Pluripotent Stem Cells into Neural Progenitor Cells. | Choi WY et al. | — | 2020 | → |
| Properties of differentiated SH-SY5Y grown on carbon-based materials. | Yoon SB et al. | — | 2020 | → |
| Review: <i>In vitro</i> Cell Platform for Understanding Developmental Toxicity. | Xie J et al. | — | 2020 | → |
| The Promise and Perils of Compound Discovery Screening with Inducible Pluripotent Cell-Derived Neurons. | Sharlow ER et al. | — | 2020 | → |
| Differentiation of lymphoblastoid-derived iPSCs into functional cardiomyocytes, neurons and myoblasts. | Poulin H et al. | — | 2019 | → |
| Early Actions of Neurotransmitters During Cortex Development and Maturation of Reprogrammed Neurons. | Ojeda J et al. | — | 2019 | → |
| Next-generation disease modeling with direct conversion: a new path to old neurons. | Traxler L et al. | — | 2019 | → |
| Recent Expansions on Cellular Models to Uncover the Scientific Barriers Towards Drug Development for Alzheimer's Disease. | Dubey SK et al. | — | 2019 | → |
| Role of Human-Induced Pluripotent Stem Cell-Derived Spinal Cord Astrocytes in the Functional Maturation of Motor Neurons in a Multielectrode Array System. | Taga A et al. | — | 2019 | → |
| The Application of Neural Stem/Progenitor Cells for Regenerative Therapy of Spinal Cord Injury. | Yu C et al. | — | 2019 | → |
| Uncovering the Functional Link Between <i>SHANK3</i> Deletions and Deficiency in Neurodevelopment Using iPSC-Derived Human Neurons. | Huang G et al. | — | 2019 | → |
| Uncovering True Cellular Phenotypes: Using Induced Pluripotent Stem Cell-Derived Neurons to Study Early Insults in Neurodevelopmental Disorders. | Fink JJ et al. | — | 2018 | → |